Cargando…
Can the peptide receptor radionuclide therapy [(177)Lu]Lu-DOTA-TATE provide a net benefit for NET patients?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591180/ https://www.ncbi.nlm.nih.gov/pubmed/34912477 http://dx.doi.org/10.1016/j.ejcsup.2021.06.001 |
| _version_ | 1784599165778526208 |
|---|---|
| author | Caplin, Martyn E. |
| author_facet | Caplin, Martyn E. |
| author_sort | Caplin, Martyn E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8591180 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85911802021-12-14 Can the peptide receptor radionuclide therapy [(177)Lu]Lu-DOTA-TATE provide a net benefit for NET patients? Caplin, Martyn E. EJC Suppl Editorial Elsevier 2021-11-09 /pmc/articles/PMC8591180/ /pubmed/34912477 http://dx.doi.org/10.1016/j.ejcsup.2021.06.001 Text en © 2021 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Editorial Caplin, Martyn E. Can the peptide receptor radionuclide therapy [(177)Lu]Lu-DOTA-TATE provide a net benefit for NET patients? |
| title | Can the peptide receptor radionuclide therapy [(177)Lu]Lu-DOTA-TATE provide a net benefit for NET patients? |
| title_full | Can the peptide receptor radionuclide therapy [(177)Lu]Lu-DOTA-TATE provide a net benefit for NET patients? |
| title_fullStr | Can the peptide receptor radionuclide therapy [(177)Lu]Lu-DOTA-TATE provide a net benefit for NET patients? |
| title_full_unstemmed | Can the peptide receptor radionuclide therapy [(177)Lu]Lu-DOTA-TATE provide a net benefit for NET patients? |
| title_short | Can the peptide receptor radionuclide therapy [(177)Lu]Lu-DOTA-TATE provide a net benefit for NET patients? |
| title_sort | can the peptide receptor radionuclide therapy [(177)lu]lu-dota-tate provide a net benefit for net patients? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591180/ https://www.ncbi.nlm.nih.gov/pubmed/34912477 http://dx.doi.org/10.1016/j.ejcsup.2021.06.001 |
| work_keys_str_mv | AT caplinmartyne canthepeptidereceptorradionuclidetherapy177luludotatateprovideanetbenefitfornetpatients |